Cancer Treatment Reviews
Volume 30, Issue 7 , Pages 643-650, November 2004

Evaluating the role of dexrazoxane as a cardioprotectant in cancer patients receiving anthracyclines

Institut Curie, 26 Rue d'Ulm, 75005 Paris, France

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(04)00102-1

doi:10.1016/j.ctrv.2004.06.002

Cancer Treatment Reviews
Volume 30, Issue 7 , Pages 643-650, November 2004

Article Tools

* Image Usage & Resolution